EVIO Inc EVIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $18,283.53
- Volume/Avg
- 10.0 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
EVIO Inc is engaged in providing analytical testing and advisory services to the emerging legalized cannabis industry. The company performs analytical testing for cannabis and cannabis products including hemp and CBD products. The company tests products to verify to meet regulatory requirements for sale. The company also provides consulting services for the residential and commercial construction and remodeling industry.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 48
- Website
- http://www.evioinc.com
Valuation
|
Metric
|
EVIO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
EVIO
Financial Strength
|
Metric
|
EVIO
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.06 |
Interest Coverage | −2.08 |
Quick Ratio
EVIO
Profitability
|
Metric
|
EVIO
|
|---|---|
Return on Assets (Normalized) | −55.70% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −32.69% |
Return on Assets
EVIO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wwlrshpddd | Wytx | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Qrnzmhskx | Lbmhwm | $68.1 Bil | |
HLN
| Haleon PLC ADR | Vdhwkmgnn | Rrc | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kjrjjmqk | Bqgb | $14.3 Bil | |
VTRS
| Viatris Inc | Wccvpwppr | Tjv | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Gdftwlbm | Hctw | $11.9 Bil | |
CTLT
| Catalent Inc | Krbwldwp | Jqhknw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rryjcyfln | Mbd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ddfftfpyd | Kzf | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rglzwrgj | Tbwgw | $3.4 Bil |